ALPINION MEDICAL SYSTEMS SHOWCASING THE LATEST INTELLIGENT ULTRASOUND TECHNOLOGY AT RSNA 2022
Unveiling Upgraded Top-Tier 'X-CUBE 90 on GPX' and Debuting Value Console 'X-CUBE 60' Unit Are Among the New-Generation of Diagnostic Ultrasound Systems to Be Demonstrated at the Radiological Society of North America's Annual Medical Exhibition SEOUL, South Korea, Nov. 10, 2022 /PRNewswire/ -- ALPINION Medical Systems, a leading brand in ultrasound technology...
Medison Pharma Announces Expansion of the Multi-Territorial Agreement with Immunocore into Latin America
With this latest expansion, Medison's global footprint is now extended across Israel, Central and Eastern Europe, Canada, Asia-Pacific and Latin America, offering patients in international markets improved access to highly innovative therapies. PETACH TIKVAH, Israel, Nov. 9, 2022 /PRNewswire/ -- Medison Pharma ("Medison"), a global pharma company focused on providing access to...
TOOsonix announces granted patents for its non-invasive treatments of dermatological conditions
TOOsonix A/S secures intellectual property rights in USA, Europe and China. The patents define methods for non-invasive and real-time image-guided treatment of skin using therapeutic ultrasound. HOERSHOLM, Denmark, Nov. 9, 2022 /PRNewswire/ -- TOOsonix A/S, a pioneer in high intensity focused ultrasound (HIFU) technology for dermatology, today announced that the United States Patent and Trademark Office (USPTO) has granted...
Mentice Receives Grant from Sweden’s Innovation Agency to Improve Synthetic Image Generation
GOTHENBURG, Sweden, Nov. 9, 2022 /PRNewswire/ -- Mentice has received a 3 million SEK grant from the Swedish government agency for innovation, Vinnova, to improve realism in Mentice virtual reality software environment with a focus on synthetic image generation. Mentice will be a part of a joint European research project called the TASTI project, financed by Vinnova within the Eureka...
Transcenta to Hold 3 Exchange Sessions on Post-SITC Business Update Call & TST003 data release and pipeline development progress update
SUZHOU, China, Nov. 9, 2022 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical-stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development, and manufacturing of antibody-based therapeutics, announces that the management team will collaborate with major brokerage firms and asset management firms to organize three exchange sessions in November 2022 as follows: 1) Transcenta TST003 data release and...
Strong business performance in 9M/2022: Exyte increases order intake, sales, and profitability
Order intake up by more than 25% year-on-year, marking a new 9M-high with €6.5 billion Sales volume increased by almost 60% to €5.3 billion Strong increase in sales in all three business segments Adjusted EBIT increased by 73% to €308 million; adjusted EBITDA rose by 70% to €340 million Acquisition of...
NICOMATIC ANNOUNCES GLOBAL DISTRIBUTION PARTNERSHIP WITH PEI GENESIS
Harsh-Environment Connector Manufacturer Announces PEI Genesis as its latest Global Distributor HORSHAM, Pa., Nov. 9, 2022 /PRNewswire/ -- Nicomatic, a global manufacturer of creative harsh-environment interconnect solutions, announces a global distribution agreement with PEI-Genesis, headquartered in Philadelphia, Pennsylvania. The partnership will bring a key interconnect supplier to Nicomatic's growing distribution channel, enhancing...
Axiomtek launches the newest medical grade artificial intelligence computing system – mBOX100
TAIPEI, Nov. 9, 2022 /PRNewswire/ -- Axiomtek – a world-renowned leader relentlessly devoted to the research, development, and manufacturing of innovative and reliable industrial computer products of high efficiency – is pleased to announce the release of the mBOX100, a medical-grade edge AI computing system with dual 4K displays. This slim-type medical...
JW Therapeutics Announces its Cell Immunotherapy Drugs Have Successfully Benefited 300 Patients
SHANGHAI, Nov. 9, 2022 /PRNewswire/ -- JW Therapeutics (HKEX: 2126), an independent and innovative biotechnology company focusing on developing, manufacturing and commercializing cell immunotherapy products, announced that as of November 8, 2022, its cell immunotherapy drugs (marketed products and candidate drugs included) have been successfully infused for treatment in 300 patients (clinical studies and commercialization included), bringing the hope...
Siemens Healthineers to demonstrate the remote capabilities of Corindus CorPath GRX Robotic System using Mentice VIST ® Simulator
GOTHENBURG, Sweden, Nov. 9, 2022 /PRNewswire/ -- Mentice, a world leader in simulation solutions for image-guided interventional therapies, announced today that Siemens Healthineers China is showcasing the remote capabilities of the Corindus CorPath GRX Robotic PCI system by using the Mentice VIST ® Virtual Patient simulator. This year's China International Import Expo (CIIE 2022) will be the first event to...
